||GABARAPL2 Rabbit Recombinant mAb
||Phospho-HSF1(S326) Rabbit Recombinant mAb
||Dexmedetomidine is a sedative medication used by intensive care units and anesthetists.
||CCR7 Rabbit Recombinant mAb
||FOXO3A Rabbit Recombinant mAb
||Cdk6 Rabbit Recombinant mAb
||CD36 Rabbit Recombinant mAb
||Cyclosporin A is an immunosuppressive agent, binds to the cyclophilin and then inhibits calcineurin with IC50 of 7 nM in a cell-free assay, widely used in organ transplantation to prevent rejection.
||Nifedipine is a dihydropyridine calcium channel blocker, used to lower hypertension and to treat angina.
||Azacitidine is a nucleoside analogue of cytidine that specifically inhibits DNA methylation by trapping DNA methyltransferases.
||Valproic acid is a fatty acid with anticonvulsant properties used in the treatment of epilepsy. It is also a histone deacetylase inhibitor and is under investigation for treatment of HIV and various cancers.
||Octocrylene is an organic compound used as an ingredient in sunscreens and cosmetics.
||Vorinostat (SAHA, MK0683)
||Vorinostat (suberoylanilide hydroxamic acid, SAHA) is an HDAC inhibitor with IC50 of ~10 nM in a cell-free assay.
||Benznidazole is a nitroimidazole derivative having an antiprotozoal activity by interfering with parasite protein biosynthesis, influencing cytokines production and stimulating host phagocytosis.
||Albiglutide is a glucagon-like peptide-1 agonist (GLP-1 agonist).
||Butylscopolamine Bromide, is a peripherally acting antimuscarinic, anticholinergic agent used as an abdominal-specific antispasmodic.
||Colchicine is a microtubule polymerization inhibitor with an IC50 of 3 nM.
||Tacrine hydrochloride hydrate
||Tacrine is a centerally active cholinesterase inhibitor that has been used to counter the effects of muscle relaxants, as a respiratory stimulant, and in the treatment of Alzheimer's disease and other central nervous system disorders. It also acts as a histamine N-methyltransferase inhibitor.
||Thiotepa(Thioplex) is an alkylating agent used to treat cancer.
||Boceprevir is an oral, direct acting hepatitis C virus (HCV) protease inhibitor with Ki value of 14 nM for NS3. It is used in combination with other antiviral agents in the treatment of chronic hepatitis C, genotype 1.